16th World ADC London
23rd – 26th February 2026 | London, UK
Returning as the longest-standing and definitive ADC forum in Europe, the 16th World ADC London Summit is the week for anyone working in or interested to learn about bioconjugates. Leverage cutting-edge R&D, development strategy, and unparalleled networking opportunities to harness ADC innovation and maximise the therapeutic index of your ADCs.
With 5 streams of end-to-end content spanning discovery, preclinical and translation, clinical lessons, process and analytical development, and manufacturing and supply chain: the 2026 agenda has been infused with trailblazing design, development, and production innovations to overcome patient resistance mechanisms and push ADCs to earlier line oncology treatments.
Join 115+ ADC Expert Speakers from leading companies including AbbVie, Eli Lilly, Pfizer, Astellas Pharma, Daiichi-Sankyo, AstraZeneca, GSK and many more to harness Global ADC Innovation to Redefine Precision Cancer Treatment in Europe.
Uniting 800+ senior European ADC decision-makers across biopharma, clinicians, service providers, investors, and regulators, World ADC London is proud to bring the community together to kick off 2026 and shape the future of ADC development.
See more here – https://ter.li/g1i8h8
P.S. Register today and access your 10% discount code, exclusively for the Oncology News Today audience – ONT6289710
Discover the full 2026 programme and registration details here –https://ter.li/n0zzoj
